INCR - Intercure Ltd.

1.31
0.030   2.290%

Share volume: 18,648
Last Updated: 04-07-2025
Pharmaceutical Products/Pharmaceutical Preparations: 0.00%

PREVIOUS CLOSE
CHG
CHG%
$1.28
0.03
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
8%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 20%
Performance
5 Days
-2.25%
1 Month
-17.60%
3 Months
-18.13%
6 Months
-18.13%
1 Year
-18.13%
2 Year
-18.13%
Key data
Stock price
$1.31
P/E Ratio 
N/A
DAY RANGE
$1.27 - $1.43
EPS 
N/A
52 WEEK RANGE
$1.27 - $1.70
52 WEEK CHANGE
-$18.12
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-15-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$14,528
AVERAGE 30 VOLUME 
$12,426
Company detail
CEO: Alexander Rabinovitch
Region: US
Website: intercure.co
Employees: 350
IPO year: 2019
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

InterCure Ltd. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector.

Recent news
loading